Modus Therapeutics (private company)
See something wrong or missing? Let us know
Offices:Stockholm
Industry:Health services
Business model:B2B
Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.
Investors:
we tracked 5 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 19.35M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Modus Therapeutics
Name | Criteria | |
---|---|---|
![]() |
Aprea Therapeutics
60%
|
|
![]() |
Asarina Pharma
50%
|
|
![]() |
BoneSupport
50%
|
|
![]() |
Pharmanest
50%
|
|
![]() |
Priothera Limited
50%
|
|
![]() |
SynOx Therapeutics
50%
|
|
![]() |
Forendo Pharma
45%
|
|
![]() |
Gesynta Pharma
45%
|
|
![]() |
Scint-X
40%
|
|
![]() |
Doctrin
38%
|
|